Rx Medicare

The U.S Food and Drug Administration amended its March 30, 2009, action warning manufacturers to stop the production and distribution of certain unapproved prescription opioids, to allow the continued marketing and distribution of one particular type of opioid — a high concentrate morphine sulfate oral solution — on an interim basis.

Read More…

Related Posts

• FDA Approves Opioid Pain Reliever With Required Risk Reduction Plan
• Illinois Hospital Assessment Plan Stalled Because Of Blagojevich’s Legal Troubles, State Money Shortage
• Medicare Ends Contract With Fox Insurance Company Drug Plan
• Louisiana, Oklahoma, Mich., Arizona Plan Medicaid Cuts; N.C.’s Prison Health Costs
• Alkermes Announces Positive Results For Phase 1 Study Of New Drug Candidate For Treatment Of Opioid-Induced Constipation
• AMA Unhappy With Senate Plan For Medicare ‘Doc Fix’
• State Round Up: Florida Considers Eliminating Popular Medicaid Plan; State Program For Low-Income Adults Changing In Minn.
• Study Reveals Predictors Of Long-term Opioid Use For Back Pain
• In Chronic Pain Patients, Higher Opioid Dose Linked To Overdose Risk
• Higher opioid dose linked to overdose risk in chronic pain patients
• Deaths from opioid use have doubled; five-fold increase in oxycodone deaths
• Adolor Corporation Initiates Clinical Testing In Opioid Bowel Dysfunction Program
• UGL Unicco Flu Preparedness And Business Continuity Plan Combats The Spread Of The H1N1 Virus
• House Republicans Offer Health Overhaul Plan
• Alkermes Announces Initiation Of Phase 1 Clinical Study Of ALKS 37 For The Treatment Of Opioid-Induced Constipation

Tags: adopts, interim, medically, necessary, opioid, plan, shortage

This entry was posted on Friday, April 17th, 2009 at 10:04 am and is filed under Analgesics Pain Migraine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.